- /
- Supported exchanges
- / US
- / MLAB.NASDAQ
Mesa Laboratories Inc (MLAB NASDAQ) stock market data APIs
Mesa Laboratories Inc Financial Data Overview
Mesa Laboratories, Inc. develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. The Sterilization and Disinfection Control segment offers biological, chemical, and cleaning indicators, used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes in the pharmaceutical, medical device, and healthcare industries. This segment also provides sterility assurance testing and laboratory services to the dental and pharmaceutical industries. The Biopharmaceutical Development segment develops, manufactures, sells, and services automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Its Clinical Genomics segment offers MassARRAY, a genetic analysis tool system, and related consumables, including chips, panels, and chemical reagent solutions used by clinical labs to analyze DNA samples for hereditary disease screenings, pharmacogenetics, oncology related applications, and toxicology research. The Biopharmaceutical Development segment provides automated systems, such as Gyrolab xPand and Gyrolab xPlore hardware and software, Gyrolab Bioaffy consumable microfluidic disks, Gyrolab kits and Rexxip buffers for protein analysis; and PurePep Symphony and Chorus instruments for peptide synthesis. Its Calibration Solutions segment offers quality control products to measure and calibrate critical parameters in applications, such as renal care, gas flow, environmental and process monitoring, and torque testing in pharmaceutical, laboratory, medical device, manufacturing, industrial, and environmental applications. This segment's products include continuous monitoring systems, data loggers, and torque testing systems under the DialyGuard, DryCal, DataTrace, and ViewPoint brands. Mesa Laboratories, Inc. was incorporated in 1982 and is headquartered in Lakewood, Colorado.
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Mesa Laboratories Inc (top by weight)
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Or get access to advanced financial data starting only $19.99
Get Mesa Laboratories Inc data using free add-ons & libraries
Get Mesa Laboratories Inc Fundamental Data
Mesa Laboratories Inc Fundamental data includes:
- Net Revenue: 250 M
- EBITDA: 45 437 K
- Earnings Per Share: 0
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
End-of-day & Earnings data
What’s included:
- Latest Release: 2026-08-10
- EPS/Forecast: 2.55
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Mesa Laboratories Inc News
New
Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary
Mesa Laboratories, Inc. Q1 2027 Earnings Call Summary - Moby Strategic Diagnosis and Operational Pivot Our analysts just identified a stock with the potential to be the next Nvidia. Tell us how you ...
Mesa Laboratories targets 1.5–1.75x net leverage by fiscal 2027 exit while resetting Gyrolab launch to fiscal 2028
Earnings Call Insights: Mesa Laboratories (MLAB) Q1 2027 MANAGEMENT VIEW * CEO Siddhartha Kadia framed his first call around execution fixes and capital allocation, saying, "Mesa is a set of durab...
Mesa Laboratories declares $0.16 dividend
* Mesa Laboratories (MLAB [https://seekingalpha.com/symbol/MLAB]) declares $0.16/share quarterly dividend [https://seekingalpha.com/pr/20573248-mesa-labs-declares-quarterly-dividend], in line with p...
3 Stocks Estimated To Be Trading 16.4% To 42% Below Intrinsic Value
In the last week, the United States market has stayed flat, yet it is up 26% over the past year with earnings forecast to grow by 17% annually. In such a robust market environment, identifying stocks ...
Corporate Events Calendar & News package for
Or get access to advanced financial data starting only $19.99
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.